Geneva Advisors’s Precigen PGEN Stock Holding History

Geneva Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-21,371	Closed	-$718K	–	742
2016 Q1	$718K	Buy	+21,371	New	+$673K	0.01%	359

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geneva Advisors's PGEN Position: Q2 2016 in Review

Geneva Advisors sold out of Precigen (PGEN) in Q2 2016, closing a stake of 21,371 shares — an estimated $718K sold.

Geneva Advisors first reported a position in PGEN in Q1 2016 and held it in 1 quarter. The position peaked at $718K in Q1 2016. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.

Geneva Advisors reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
Geneva Advisors sold 21,371 Precigen shares in Q2 2016, an estimated $718K.
Geneva Advisors first reported a position in Precigen in Q1 2016 and held it in 1 quarter.
Geneva Advisors's Precigen position peaked at $718K in Q1 2016.
169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.

Based on Geneva Advisors's 13F filing for Q2 2016, filed 8 Aug 2016.